The Medical Services Advisory Committee will reconsider Janssen's CAR-T therapy CARVYKTI for multiple myeloma almost one year after Health Minister Mark Butler cited the treatment as evidence of the system's 'clunky' decision-making and the cause of unnecessary deaths.
Patients are still dying waiting for access almost one year on from 'clunky' admission
April 2, 2024 Latest NewsBioPharmaNews of the Day![](https://e76bb9fd1f54a7a912eb-40f6ec802f763655ee14c32dfe77820e.ssl.cf4.rackcdn.com/2c9b3dd9ce8bf0ec127d7cc941b6cc6b.png)
Latest Video
New Stories
-
The 'Week in Review' Podcast - 26 July
July 26, 2024 - - Podcast -
'We approached stakeholders that were highly engaged with the HTA review process'
July 26, 2024 - - Latest News -
Preaching transparency and not practising it is the worst possible look
July 26, 2024 - - Latest News -
Cartherics announces new licensing agreement for innovative cardiac cell therapy
July 25, 2024 - - Latest News -
New large study shows vaccination halves the risk of patients suffering Long-COVID
July 25, 2024 - - Latest News -
These layered levels of privilege are not making decision-making or the system better
July 25, 2024 - - Latest News -
Telix completes significant raise that could be used for acquisitions
July 25, 2024 - - Latest News